Ten reasons why A1C should not be used as a screening tool for T2DM
Screening of a disease can be understood as detecting a disease in an individual before clinical symptoms are apparent. In case of diabetes mellitus, as of now, the preferred screening test is still fasting blood sugar (FBS). Glycated hemoglobin (A1C) however, did make its way into guidelines as a d...
Main Author: | Shahar, Mohammad Arif |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/58564/ http://irep.iium.edu.my/58564/1/Debate%20HbA1C.pdf |
Similar Items
-
Choice of antidiabetic agents in heart failure
by: Shahar, Mohammad Arif
Published: (2017) -
Prevalence of thyroid disorders in Malaysia
by: Shahar, Mohammad Arif
Published: (2017) -
TrueDx TSH assay is an acceptable screening test for both hypo- and hyperthyroidism in the general population: correlation between trueDx TSH assay and the standard 3rd Generation TSH Chemoluminiscence Immunoassay (CMIA)
by: Shahar, Mohammad Arif, et al.
Published: (2017) -
Misleading thyroid-stimulating hormone results due to immunoassay interference: A case report
by: Goh, Kian Guan, et al.
Published: (2017) -
Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
by: Goh, Kian Guan, et al.
Published: (2017)